Market Overview
The global Metabolic Genetic Testing market was valued at USD 1,114 million in 2024 and is projected to reach USD 1,811 million by 2031, exhibiting a CAGR of 7.4% during the forecast period.
Metabolic genetic testing refers to a type of genetic testing that focuses on identifying genetic variations or mutations that can impact a person's metabolism. These tests aim to diagnose and understand inherited metabolic disorders, which are conditions caused by genetic defects that affect the body's normal metabolic processes.
USD 1,114 million in 2024
USD 1,811 million by 2031
CAGR of 7.4%
Single Gene Testing
Multi-Gene Panels
Multi-gene panels are gaining significant traction as they provide comprehensive metabolic profiling, enabling clinicians to identify complex interactions between multiple genetic factors. The holistic approach reduces diagnostic odysseys and enhances personalized treatment planning.
By Application
Inborn Errors of Metabolism
Pharmacogenomics
Newborn Screening
Preventive Health Management
Newborn
https://www.24lifesciences.com
Our Key Players
Quest Diagnostics Inc. (United States)
Laboratory Corporation of America Holdings (United States)
Invitae Corporation (United States)
Ambry Genetics (United States)
Color Health Inc. (United States)
Myriad Genetics Inc. (United States)
https://www.24lifesciences.com
